TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer

NCT04887506 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
107
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tavanta Therapeutics